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Abstract
The objective of this study was to identify the impact of West Nile virus (WNV) and Toscana virus (TOSV) in febrile diseases of unknown
aetiology in Eastern Thrace, Turkey; this study was conducted during August–October 2012, and included 18 clinical cases and 296 blood
donors for local serosurveillance. Antibodies were determined via commercial assays and further tested for speciﬁcity via neutralization assays
(NA). Viral RNAs were sought via speciﬁc and/or generic primers. WNV infections were diagnosed in seven patients (38.8%), detected via
RNA+IgM in four, RNA in one and IgM and low avidity IgG in two cases. Themost common symptomwas fever (>38°C), followed by headache,
malaise/fatigue, myalgia/arthralgia, muscle stiffness/lower back pain, anorexia, nausea/vomiting, diarrhoea, supraorbital/retrobulbar pain and
abdominal pain.Neurological symptomswere noted in one individual.WNV strains in RNA-detectable patientswere characterized as lineage 1.
TOSV RNA or IgM were identiﬁed in two individuals with conﬁrmedWNV infections and in one patient without evidence ofWNV exposure.
The clinical and laboratory ﬁndings in individuals withWNV/TOSV co-infectionwere comparable to those inWNV-induced disease. TheTOSV
strain in the patient with detectable viral RNA was characterized as genotype A. In local blood donors, seroreactivity for speciﬁc WNV and
TOSV immunoglobulins was observed in 1.7% (5/296) and 14.4% (26/180), respectively. These ﬁndings indicate the emergence of WNV and
TOSV-associated diseases in Eastern Thrace. WNV/TOSV co-infections were documented for the ﬁrst time.
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Introduction
West Nile virus (WNV) and Toscana virus (TOSV) are
causative agents of major vector-borne viral infections that
induce central nervous system manifestations as well as febrile
diseases in affected individuals [1,2]. WNV is a mosquito-borne
Flavivirus (family Flavivirdae) maintained in an enzootic cycle
between birds as amplifying hosts and mosquito vectors [1].
WNV infections in humans usually remain subclinical; a febrile
illness called West Nile fever develops in 20% of exposed
persons and neuroinvasive disease in <1% [3]. Since 1994, the
virus has caused outbreaks of severe disease in humans and
horses in Europe and the Mediterranean Basin [4]. TOSV,
included in the Phlebotomus fever group in the Phlebovirus genus
of the Bunyaviridae family along with Sandﬂy fever and Sicilian
and Naples viruses, is transmitted to humans by the bite of
phlebotomine sandﬂies [5]. While all three viruses may induce
ª2013 The Authors
Clinical Microbiology and Infection ª2013 European Society of Clinical Microbiology and Infectious Diseases
ORIGINAL ARTICLE VIROLOGY
a self-limited febrile disease known as phlebotomus, papatacci
or sandﬂy fever, TOSV, having a distinct neurotropism, is
considered to be one of the leading causes of human aseptic
meningitis in endemic countries around the Mediterranean
basin [5,6]. In this study, the activity and impact of WNV and
TOSV were investigated in Eastern Thrace, Turkey, where no
previous data were available.
Materials and Methods
Study area, setting and clinical cases
The study was carried out in the northwestern part of the
Turkish Republic, also called the Eastern Thrace region, which
includes territories of ﬁve provinces (Edirne, Tekirdag, Kirk-
lareli, Canakkale and Istanbul) with a population of 1 569 388
(www.kalkinma.gov.tr/DocObjects/Download/10211/TR21_Tra
kya_Bolge_Plani.pdf). The region is bordered on the west-
northwest by Greece and Bulgaria and separated from
Anatolia or Asia minor by the Sea of Marmara (Fig. 1).
During early August 2012 two cases of febrile disease of
unidentiﬁed aetiology were referred to the infectious diseases
clinic of the Haydarpasa Training and Research Hospital of
Gulhane Military Medical Academy. The cases were military
recruits, located in the Corlu district of Tekirdag province
(Fig. 1). As the preliminary evaluations indicated WNV
infections, this study was undertaken to identify further cases
and asymptomatic exposure in the region. The study was
approved by the Turkish Ministry of Health Haydarpasa
Research and Training Hospital ethical board (HNEAH-KAEK
2012/197).
Adult patients with the clinical diagnosis of febrile disease of
presumed viral aetiology observed during late July to early
October 2012 at state hospitals in the Corlu and Cerkezkoy
districts of Tekirdag province, infectious diseases clinics of
Trakya University Hospital in Edirne province and Haydarpasa
State and Military Research and Training Hospitals in Istanbul
province were included in the study (Fig. 1). After informed
consent, physical examination and laboratory tests, which
included haemoglobulin, leucocyte and platelet counts, sedi-
mentation rate, C-reactive protein (CRP), alanine aminotrans-
ferase (ALT), aspartate aminotransferase (AST), creatinine
phosphokinase (CPK), lactate dehydrogenase (LDH), total
protein, albumin and creatinine, were performed. The partic-
ipants ﬁlled out a questionnaire to identify risk factors for
vector-borne infections. Sera and/or cerebrospinal ﬂuid (CSF)
were obtained from patients within 1–10 days after the onset
of symptoms, and subjected to nucleic acid puriﬁcation using
the High Pure Viral Nucleic Acid Kit (Roche Diagnostics,
Mannheim, Germany) and reverse transcription using the
RevertAid First Strand cDNA Synthesis Kit (Thermo Scientiﬁc,
Tokyo, Japan). For the detection of WNV RNA, nested and
real-time reverse transcription PCRs, targeting distinct regions
of the viral genome, were employed [7,8]. TOSV and other
FIG. 1. Map of the Eastern Thrace region,
showing the study area. Provincial
boundaries and district borders in
Tekirdag province are demonstrated. See
text for details (4, institution for patient
evaluation;▲, institution where conﬁrmed
WNV cases were identiﬁed; , mosquito
sampling location).
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phleboviruses were sought via a generic nested PCR utilizing
degenerated primers [9].
Sera from clinical cases were screened for WNV IgM and
IgG class immunoglobulins via commercial enzyme-linked
immunosorbent assays (ELISAs) and immunoﬂuorescence
assays (IFAs) (anti-WNV ELISA and IFA, Euroimmun, Luebeck,
Germany).
In IgG-positive samples, immunoglobulin avidity was deter-
mined via a commercial assay (WNV avidity ELISA, Euroim-
mun). For pathogenic phleboviruses including TOSV, a
commercial IFA was employed (Sandﬂy Fever Virus Mosaic I
IgG and IgM IFA, Euroimmun).
Positive samples in the commercial WNV and TOSV assays
were subsequently analysed via neutralization assays (NAs) to
conﬁrm antibody speciﬁcity, using WNV strain NY99-4132,
TOSV strain ISS.Phl.3 and Vero cells (ATCC CCL81) as
previously described [10,11].
Blood donor surveillance
Sera from volunteer blood donors, obtained during Septem-
ber–October 2012 in Corlu and Cerkezkoy districts were
screened for WNV and TOSV immunoglobulins via a com-
mercial ELISA and IFA (Sandﬂy Fever virus type Toscana IgG
and IgM IFA, Euroimmun). Reactive samples were included in
NA and WNV IgG avidity assays.
Sequencing and phylogenetic analysis
Nested PCR amplicons were cleaned up using a High Pure
PCR Product Puriﬁcation Kit (Roche Diagnostics) and sub-
sequently sequenced via forward and reverse primers using an
ABI Prism 310 Genetic Analyzer (Applied Biosystems, Foster
City, CA, USA). Obtained sequences were handled using CLC
Main Workbench v5.5 (CLCBio, Aarhus, Denmark). Phyloge-
netic analyses were performed using the Jukes-Cantor substi-
tution rate model with 500 bootstrap replicates. Maximum
likelihood trees were generated based on a UPGMA tree.
Results
Evaluation of clinical cases
A total of 18 cases were evaluated during the study period.
Evidence of acute WNV infections was identiﬁed in seven
patients (38.8%). Diagnosis was based on viral RNA detection
in one (1/7), viral RNA and NA-conﬁrmed IgM detection in
four (4/7) and NA-conﬁrmed IgM and low avidity IgG
detection in two cases (2/7). The average time for hospital
admission and sampling after the onset of symptoms in cases
with detecteable RNA was 1 day, whereas it was 2 and
10 days for serologically conﬁrmed cases. Maximum
composite likelihood analyses demonstrated 82.8–98.8% and
81.97–99.60% similarity among patient-derived WNV
sequences and sequences from equine/human cases from
Central Anatolia, respectively. All sequences belonged to the
WNV lineage 1 clade 1a (Fig. 2a).
The most common symptom observed in laboratory-con-
ﬁrmed WNV infections was fever (38–39.5°C), noted in all
patients (7/7), followed by headache (5/7), malaise/fatigue (5/7),
myalgia/arthralgia (5/7), muscle stiffness/lower back pain (5/7),
decreased appetite/anorexia (2/7), nausea/vomiting (2/7),
diarrhoea (2/7), supraorbital/retrobulbar pain (2/7) and
abdominal pain (1/7). No form of skin rash, photophobia or
lymphadenopathy was present in any of the cases. Gastroen-
testinal symptoms were prominent in two individuals
(Table 1). Laboratory evaluations revealed leucopenia in four,
thrombocytopenia in four, elevated CPK levels in three,
elevated AST levels in three and increased sedimentation rate
in two cases. Leucocytosis and mildly elevated CRP and ALT
levels were also noted in three separate individuals (Table 1).
All patients with WNV infections recalled mosquito bites
within 10 days prior to disease onset and no other risk factor
associated with virus transmission could be identiﬁed.
One WNV-infected individual, a 65-year-old male farmer
residing in Edirne province, presented with febrile disease and
neurological manifestations, characterized by mental status
changes, confusion, neck stiffness without Kernig or Brudzin-
ski’s sign, paresis and myoclonic seizures of the right arm. CSF
examination displayed increased protein (74.2 mg/dL) and
pleocytosis comprising 70% mononuclear cells. Diffuse slow
wave activity was observed on electroencephalogram (EEG)
and magnetic resonance imaging (MRI) demonstrated bilateral
thalamic lacunar infarcts. In addition to the supportive therapy
and anti-epileptics, a single 25 mg dose of prednisolone was
administered. Although the patient recovered from the febrile
condition, no neurological improvement was observed despite
anti-epileptics and physical therapy after 35 days. All remaining
patients responded favourably to the supportive therapy, with
fever and other symptoms subsiding within an average of 3–
4 days, and were discharged without residual sequelae.
In one individual with WNV RNA and speciﬁc IgM, generic
phlebovirus PCR also yielded positive results (Table 1, patient
No.6). After repeat assays and sequencing, the amplicons were
characterized as TOSV, grouped with genotype A strains
(Fig. 2b). The sequence was identical and 99.19% similar to
TOSV sequences detected in Central Anatolia during 2009
(not included in the tree; GenBank accession,HM151316) and
2012, respectively. Moreover, a neutralizing TOSV IgM reac-
tivity was observed in another individual with serologically
conﬁrmed WNV (Table 1, patient no.7). Symptoms and clinical
presentation of these cases were indistinguishable from West
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Nile fever patients (Table 1). Moreover, a 35-year-old house-
wife from Cerkezkoy province presenting with febrile disease
with negative WNV assays also demonstrated a neutralizing
TOSV IgM without viral RNA in serum. Lacking a history of
insect bites, this patient had leucopenia, thrombocytopenia,
and elevated AST (128 IU/L), ALT (108 IU/L) and LDH
(1056 U/L) (Table 1 patient No.8).
Virus exposure in blood donors
WNV and TOSV exposures were sought in 296 and 180
asymptomatic blood donors, respectively. WNV seroreactivity
was observed in 22 individuals (7.4%), whereas speciﬁcity
could be conﬁrmed via NA in ﬁve (1.7%). High avidity IgGs
were detected in all NA-conﬁrmed donors, also accompanied
by IgM in one individual. A higher rate of TOSV exposure was
observed, detected in 42 (23.3%) and conﬁrmed in 26 (14.4%)
donors. The majority of the individuals with TOSV exposure
had IgM antibodies (22/26), suggesting recent exposure. In two
(0.6%) blood donors, dual exposure to these viruses was
identiﬁed by the detection of WNV IgG with TOSV IgG and/or
IgM. The distribution of serosurveillance results is given in
Table 2.
Discussion
Following the identiﬁcation of two cases of febrile disease
associated with WNV in the Eastern Thrace region in Turkey,
further WNV and phlebovirus infections were investigated in
this region during August–October 2012 with an accompanying
(a)
(b)
FIG. 2. Neighbour-joining tree of West Nile virus (WNV) partial E protein (a) and Toscana virus (TOSV) partial L segment (b) sequences. Virus
strains represented are indicated by strain name and GenBank accession number. Bootstrap values are given in per cent. (a) Case1.THR.KC290932,
Case2.THR.KC290933, Case3.THR.KC466019, Case4.THR.KC466020 and Case5.THR.KC466021: sequences characterized in this study.
Eqn1.2011.JN828805, Eqn2.2011.JN828806 and HmnS.2012.JX310862: equine and human sequences from Central Anatolia. Cxp.KC290935,
Cxp.KC290942 and Occ.KC290941: sequences detected in mosquitoes in Eastern Thrace [21]). (b) TOSV.EThrace.KC290930: sequence
characterized in this study. TOSV.Ankara.KC290931n: human sequence detected in 2012 from Central Anatolia.
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serosurveillance study. The results revealed seven labora-
tory-conﬁrmed WNV cases and a local seroprevalence of 1.7%
in asymptomatic blood donors. Moreover, TOSV infections have
been detected in three individuals with febrile diseases with a
14.4% seroprevalence rate. In two febrile patients, labora-
tory-conﬁrmed co-infections of WNV and TOSV have been
identiﬁed via serology and/or viral RNA detection. These ﬁndings
are the ﬁrst reports ofWNV and TOSV activity from this region.
In addition, evidence of WNV and TOSV co-infections in the
same individual has been described for the ﬁrst time.
Turkey is located in the endemic zone for WNV and
serosurveillance data demonstrated animal and human WNV
exposure throughout Anatolia [12]. However, reports of
symptomatic infections have been few, mostly involving
serologically identiﬁed neuroinvasive diseases [12–14]. Here,
we described six cases of West Nile fever and one individual
with central nervous system involvement. Fever exceeding
38°C and accompanying symptoms documented in these
patients are generally in accordance with the previously
reported case series [2,3,15]. Symptoms involving the gastro-
intestinal system predominated only in two individuals
(Table 1). Detection of WNV RNA was successful if the
blood sampling could be performed within the ﬁrst day of
hospital admission. Neuroinvasive disease was documented in
TABLE 1. Clinical symptoms and laboratory ﬁndings in patients with West Nile virus (WNV) and/or Toscana virus (TOSV)
infections
No.
Age/gender/place of
residence/occupation Signs and symptomsa Laboratory ﬁndings Diagnostic assay resultsb
1 25, male, Corlu, military recruit Headache, malaise/fatigue, myalgia/arthralgia,
muscle stiffness/lower back pain
Leucopenia (2800/mm3)
Thrombocytopenia
(129 000/mm3)
Increased CPK (665 U/L)
Increased AST (51 IU/L)
WNV RNA (+), WNV IgM (+)
2 24, male, Corlu, military recruit Headache, malaise/fatigue, myalgia/arthralgia Leucopenia (3300/mm3)
Increased CPK (427 U/L)
WNV RNA (+),WNV IgM (+)
3 21, male, Corlu, military recruit Muscle stiffness/lower back pain
Supraorbital/retrobulbar pain
Thrombocytopenia
(112 000/mm3)
WNV RNA (+)
4 21, male, Corlu, military recruit Headache, malaise/fatigue, myalgia/arthralgia,
muscle stiffness/lower back pain, Supraorbital/retrobulbar
pain, abdominal pain, nausea/vomiting, anorexia, diarrhoea
Leucopenia (3100/mm3) WNV RNA (+),WNV IgM (+)
5 65, male, Edirne, farmer Headache, malaise/fatigue, myalgia/arthralgia, abdominal pain,
nausea/vomiting, anorexia, diarrhoea, neurological symptomsc
Leucocytosis (15 800/mm3)
Increased ESR (81 mm/hr)
Increased CPK (246 U/L)
WNV IgM (+)
WNV IgG (+) (low avidity)
6 21, male, Corlu, military recruit Muscle stiffness/lower back pain Thrombocytopenia
(137 000/mm3)
Increased CRP (5.2 mg/dL)
WNV RNA (+),WNV IgM (+)
TOSV RNA (+),
7 19, male, Corlu, student Headache, malaise/fatigue, myalgia/arthralgia, muscle
stiffness/lower back pain, abdominal pain
Increased ESR (45 mm/h) WNV IgM (+)
WNV IgG (+) (low avidity)
TOSV IgM (+)
8 35, female, Cerkezkoy,
housewife
Headache, malaise/fatigue, myalgia/arthralgia Leucopenia (2500/mm3)
Thrombocytopenia
(105 000/mm3)
Increased AST (128 IU/L),
ALT(108 IU/L)
Increased LDH (1056 U/L)
TOSV IgM (+)
ALT, alanine aminotrasferase; AST, aspartate aminotransferase; CPK, creatinine phosphokinase; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; LDH, lactate
dehydrogenase.
aHigh fever (>38°C) was present in all patients, whereas skin rash or lymphadenopathy was not observed.
bIgM and IgG seropositivities reported for the patients have been conﬁrmed via virus neutralization assays.
cInclude mental status changes, confusion, stiff neck and myoclonus and paresis affecting right arm. See text for details.
TABLE 2. West Nile virus (WNV) and Toscana virus (TOSV) seroepidemiology according to the sampling locations in the study
region
Location
WNV TOSV
ELISA NA IFA NA
Negative Positive Conﬁrmed Total Negative Positive Conﬁrmed Total
Corlu (41°17′23′′N,28°0′0′′E)
IgM 135 15 0 70 16 11
IgG 148 2 2 82 4 1
IgM+IgG 150 0 0 83 3 2
Total 17 (11.3%) 2 (1.3%) 150 23 (26.7%) 14 (16.3%) 86
Cerkezkoy (41°9′23′′N,27°48′37′′E)
IgM 144 2 0 80 14 11
IgG 144 2 2 91 3 0
IgM+IgG 145 1 1 72 2 1
Total 5 (3.4%) 3 (2.1%) 146 19 (20.2%) 12 (12.7%) 94
NA, neutralization assay; ELISA, enzyme-linked immunosorbent assays; IFA, immunoﬂuorescence assays.
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a 65-year-old male, who demonstrated meningoencephalitic as
well as focal neurological symptoms with increased protein and
pleocytosis in CSF. Encephalitis occurs in about 60% of
persons with WNV-associated neuroinvasive disease and is
more frequent in persons over 55 years and in those with
underlying medical conditions [16,17]. No risk factor other
than advanced age could be identiﬁed for our patient, who has
not completely recovered despite medical attention.
Five genetic lineages of WNV have been identiﬁed, and the
majority of the strains responsible for the European and the
Mediterranean outbreaks belong in Lineage 1 [4,18]. In Turkey,
human cases as well as equine infections with lineage 1 WNV
strains have been documented in 2011–2012 from Central
Anatolia [19,20]. Sequences from West Nile fever cases
identiﬁed in Eastern Thrace in this study were grouped with
lineage 1 viruses and were closely related to the strains from
Central Anatolia (Fig. 2a). These ﬁndings indicate that lineage 1
viruses are in circulation not only in Central Anatolia but in the
European part of Turkey as well. All cases have indicated recent
mosquito exposure prior to the initiation of symptoms. We
performed a ﬁeld study in locations associated with WNV
emergence in early September (Fig. 1), but a limited number of
Culex pipiens s.l. specimens, negative forWNVRNAand antigens,
could be collected. However, WNV-infected Cx pipiens s.l. and
Ochlerotatus caspius pools were identiﬁed during an arboviral
ﬁeld survey performed during early July in locations 80–100 km
west-northwest of the current sites of disease emergence [21].
These ﬁndings strongly suggest mosquito bites as the route of
WNV transmission in the Eastern Thrace region.
Outbreaks of febrile diseases due to phleboviruses, espe-
cially the recently identiﬁed phlebovirus variant Sandﬂy Fever
Turkey virus (SFTV), have been previously demonstrated and
this strain appears to be in circulation in Central Anatolia
[22,23]. Acute TOSV infections have initially been identiﬁed in
2009 in Ankara (Central Anatolia) and in 2011 in Izmir
provinces (Western Anatolia), in patients with symptoms of
mild meningitis, usually without encephalitic symptoms [14,24].
Partial L and S segment sequences detected in patients
suggested TOSV genotype A strains to be prevalent, with
serosurveillance data indicating asymptomatic human exposure
in these regions [24,25]. In this study, we have identiﬁed an
individual with febrile disease due to TOSV via IgM detection
and a conﬁrmed TOSV seroprevalence of 14.4% in the study
region. Furthermore, TOSV RNA or neutralizing IgM antibod-
ies were identiﬁed in two individuals with conﬁrmed WNV
infections, indicating dual infections with these agents. The
symptoms and laboratory ﬁndings noted in WNV/TOSV
co-infected individuals were comparable to those in WNV-
induced febrile disease (Table 1). Virus serosurveillance also
provided indirect evidence for WNV/TOSV co-infections by
the demonstration of WNV IgG and or TOSV IgM/IgG
in blood donors. It remains to be determined whether
simultaneous infections with WNV/TOSV are observed in
other endemic regions and result in enhanced pathogenicity
with more severe clinical outcomes in various patient
groups.
Partial sequences characterized in the patient with detect-
able TOSV RNA demonstrate the circulation of genotype A
strains in Eastern Thrace as well as in Central Anatolia and a
more widespread zone of TOSV activity than previously
anticipated [12].
Various sandﬂy species capable of transmitting TOSV as well
as other pathogenic phleboviruses have been observed in
Turkey and Phlebotomus major s.l. has been identiﬁed as the
probable SFTV vector [12,26]. Currently, sandﬂies indigenous
to Eastern Thrace are not thoroughly investigated and further
studies are required to demonstrate whether P. perﬁliewi and/
or other species, established as TOSV vectors, are present in
the region.
In conclusion, we have revealed cases of WNV and
TOSV-associated diseases as well as asymptomatic virus
exposure in the Eastern Thrace region. Moreover, the ﬁrst
co-infections of WNV and TOSV have been documented.
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